[Chemoradiation therapy: a model for treatment optimization in oncology].
This work aims at describing the wide variety of questions relative to the treatment of locally advanced non-small cell lung cancer; it shows how the advent of new results induces new questions, as well as the diversity of clinical research directions. Lung cancer represents a model of organization of multimodal therapeutic algorithms, the ultimate aim being the therapeutic optimization of the most frequent cancer.
Mornex
Françoise
F
Département de radiothérapie-oncologie, Centre hospitalier Lyon-Sud, Lyon. francoise.mornex@chu-lyon.fr
Girard
Nicolas
N
Van Houtte
Paul
P
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000532:radiotherapy*; D003131:Combined Modality Therapy / Q000379:methods; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D015201:Meta-Analysis as Topic; D020360:Neoadjuvant Therapy; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D020266:Radiotherapy, Conformal
D011838:Radiation-Sensitizing Agents